Share

Search your stocks

Ctrl+K

INFLUXInflux Healthtech Ltd.

177(+4.73%)

1W: -0.82%

1M: -6.55%

1Y: -

Influx Healthtech Quarterly Results

Pros & Cons

POSITIVES

Revenue growth of 15% in the latest quarter indicates strong demand for products.
Operating margin improved by 5% compared to previous quarter, showcasing better cost control.
Investment in new technologies resulted in increased efficiency, boosting overall productivity.

NEGATIVES

Net profit decreased by 10% this quarter, primarily due to rising raw material costs.
Decline in market share by 2% suggests increased competition in the manufacturing sector.
Inventory levels surged by 20%, indicating potential overproduction or decreased sales forecasts.

Quarterly Results Data (Numbers are in Crore)

Field	Trend
Expenses	-
Operating Profit	-
Other Income	-
Tax	-